Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study. (Q38645064)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study. |
scientific article |
Statements
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study (English)
Jin Seok Ahn
Luigi De Petris
Ramaswamy Govindan
James Chih-Hsin Yang
Brett Hughes
Hervé Lena
Santiago Viteri Ramirez
Tarek Mekhail
Alexander Spira
Walter Bordogna
Bogdana Balas
Peter N Morcos
Annabelle Monnet
Ali Zeaiter
Dong-Wan Kim
Sai-Hong Ignatius Ou